ClinicalTrials.govpublic full text
Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma
relapsed refractory multiple myeloma (rrmm)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 426725
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.